Levocarnitine
NDC 16571-762, Levocarnitine, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-762
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076858
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-762 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOCARNITINE330 mg/1
Pharmacologic classes
Carnitine Analog [EPC]; Carnitine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-762-09 | 16571076209 | 9 BLISTER PACK in 1 CARTON (16571-762-09) / 10 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f749812-8f02-4eeb-91d9-5dd6fc9fa159NADAC price for package 16571076209
GET /v1/drugs/nadac/16571076209
Use it
Look up 16571-762 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-762 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-762. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.